Measles vaccine recommended by WHO increased mortality in females 2-fold notes Peter Aaby, DMSc

Posted by .(JavaScript must be enabled to view this email address)
Thursday, March 28, 2019 11:00 am Email this article

In this 23-second video clip, Peter Aaby, DMSc, founder of the Bandim Health Project in West Africa, notes that they found that a new measles vaccine that was recommended by the WHO in 1989 increased the death rate in female infants 2-fold.

He notes that, had it been implemented, the new measles vaccine would have caused an additional 500,000 female deaths in Africa.

Peter Aaby is credited for the discovery of non-specific effects of vaccines – i.e. effects of vaccines, which go beyond the specific protective effects against the targeted diseases.

 

In 1978, Peter Aaby, DMSc established the Bandim Health Project, 
a Health and Demographic Surveillance System site 
in Guinea-Bissau in West Africa, which he has run ever since.

Peter Aaby’s group has also found that…

https://www.bandim.org/research/non-specific-effects

“The live attenuated vaccines, 
measles vaccine, oral polio vaccine, smallpox vaccine and 
BCG vaccine, seem to confer 
more general protection against 
a broad range of pathogens.”

“However, the non-live vaccines like diphtheria-tetanus-pertussis vaccine (DTP) have been associated with increased susceptibility to other pathogens, particularly in females.”

That is, live-attenuated vaccines reduce the overall risk of death, whereas non-live vaccines increase the overall risk of death.

The vaccine story 
is more complicated 
than what 
the CDC is telling us.

Articles on the same subject can be found here:

• Vaccines